I could try to answer this.
The made-in-Canada solution, this Bill C-11 and the program thereafter, is to establish biosafety and biosecurity and to protect Canadians from pathogens. It's important for us to know who holds pathogens, whether they are in risk group 2 or not. All we want to do is to know that when institutions, organizations, and laboratories hold pathogens, we actually know who these people are and that they are handling things in a safe manner, according to laboratory biosafety guidelines.
Now, for risk group 2, for the most part, we are not asking for security clearance, because we do not believe they are a bioterrorism risk.
The type of risk group 3 pathogens and all the risk group 4 pathogens, or specific toxins, we would like to discuss in the regulatory development are probably similar to those on the U.S. list--I'm not saying the list would match, but they would probably have a similar kind of approach, so that the select agent rule is about biosecurity, bioterrorism.
This bill is establishing a single, uniform standard for safety in Canada, and that's important to Canadians. Every Canadian will want to know that we actually know where laboratories are and who holds pathogens, and that whoever is holding the pathogens is handling them in a safe manner.